AI MARKET SCANNING

Castle Biosciences Inc

📅 Next Catalyst: Nov 05, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Medical Specialties
AVG HISTORICAL GAP +5.03%
MAX GAP RECORD +29.57%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CSTL
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE)
+7.32%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
-8.44%
Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE)
-6.30%
Nov 03, 2025 Earnings Release 2025-11-03 (AFTER CLOSE)
+3.62%
Aug 04, 2025 Earnings Release 2025-08-04 (AFTER CLOSE)
+29.57%
May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE)
+0.60%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
+2.85%

VOLATILITY & GAP BIAS

AVG GAP MOVE 7.6%
Bullish Gaps (10)
Bearish Gaps (3)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CSTL

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 0m +3.25%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Castle Biosciences, Inc. is a molecular diagnostics company, which offers innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗